In today’s issue: President Trump’s tariff rollout has world leaders and economists on edge as White House messaging about the levies remains inconsistent. Last week, Trump abruptly delayed most “reciprocal” tariffs while keeping a 10-percent baseline levy and raising tariffs on Chinese goods to 125 percent, prompting backlash from Beijing. Chinese President Xi Jinping warned Monday that protectionism "leads...
The adoption of the Republicans’ budget bill has thrown a spotlight onto the hot-button issue that could make or break President Trump’s domestic agenda: Medicaid. The massive government health care program is at the heart of the GOP’s plan to slash federal spending in order to trim deficits and make budget space for Trump’s new...
The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose "a major tariff" on prescription drug imports. Tariffs would disrupt international supply chains, force companies to decide whether to pass increased costs on to patients and exacerbate existing drug shortages. The administration wants more drug companies to...
A new report warns that the U.S.-UK special relationship could fracture under a second Trump administration unless Britain gets tougher on communist China.
Former Rep. Mike Rogers, who was the GOP Senate nominee in Michigan, is launching a second straight Republican run for the Senate in the crucial Great Lakes battleground state.
The Republican State Leadership Committee, which works to elect GOP lawmakers to legislative and executive offices, is spotlighting what it calls a "record" fundraising haul during the first three months of the year.
President Donald Trump's 13th week back in the Oval Office is expected to again heavily focus on tariffs after putting a 90-day pause on customized tariffs.
A report from the Congressional Joint Economic Committee Minority will be released Monday reportedly showing cuts to Medicaid Expansion funding could endanger medical treatments for drug addiction.